SOFGEN PHARMA S.A (PROCF) Net Income by Year
SOFGEN PHARMA S.A reported a net loss of $68.3M in fiscal year 2024. This represents a decrease of 269.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters SOFGEN PHARMA S.A has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PROCF Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PROCF Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More SOFGEN PHARMA S.A financials
Frequently Asked Questions
What was SOFGEN PHARMA S.A's net income in fiscal year 2024?
SOFGEN PHARMA S.A reported a net loss of $68.3M in fiscal year 2024.
How fast is SOFGEN PHARMA S.A's net income growing?
SOFGEN PHARMA S.A (PROCF) net income fell by 269.3% year over year, from $40.3M to -$68.3M in fiscal year 2024.
How has SOFGEN PHARMA S.A's net income changed over the years?
Across the 6 fiscal years this page covers, SOFGEN PHARMA S.A (PROCF) net income went from -$17.0M in fiscal year 2019 to -$68.3M in fiscal year 2024.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what SOFGEN PHARMA S.A (PROCF) reported on that line in every period on record.